ASP Isotopes Inc. Corporate Overview 2024 | Investor Presentation

ASP Isotopes Inc. is an advanced technology company leveraging 20 years of R&D to enrich isotopes for medical, semiconductor, and nuclear energy applications. The company targets three multi-billion-dollar markets, including the medical isotopes sector projected to grow from $5.1bn in 2022 to $11.4bn by 2032 at an 8.8% CAGR. ASP operates through subsidiaries including PET Labs and Quantum Leap Energy to supply enriched isotopes globally.